Huakang Biomedical Holdings Company Limited (HKG:8622)
Hong Kong · Delayed Price · Currency is HKD 0.3900
+0.0100 (2.63%)
Aug 29, 2025, 3:58 PM HKT
Huakang Biomedical Holdings Company Company Description
Huakang Biomedical Holdings Company Limited, an investment holding company, engages in the research, production, and sale of male fertility in-vitro diagnostic (IVD) reagents in the People's Republic of China.
The company provides biological reagents, including male fertility IVD reagents, parasite antibody detection reagents, and Epstein-Barr virus antibody detection reagent; and auxiliary reproductive supplies and equipment.
The company sells its products directly to hospitals and medical institutions, as well as to distributors.
Huakang Biomedical Holdings Company Limited was founded in 1992 and is based in Tsim Sha Tsui, Hong Kong.
Huakang Biomedical Holdings Company Limited
| Country | Cayman Islands |
| Founded | 1992 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 91 |
| CEO | Chunguang Zhang |
Contact Details
Address: Kimberley House Tsim Sha Tsui Hong Kong | |
| Website | huakangbiomedical.com |
Stock Details
| Ticker Symbol | 8622 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | KYG4644W1069 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Chunguang Zhang | Chief Executive Officer and Executive Director |
| Shuguang Zhang | Executive Chairman of the Board |
| Lai Yin Poon CPA (Aust.), CPA (HKICPA) | Chief Financial Officer, Compliance Officer and Executive Director |
| Jiaming He | Business Development Director |
| Yujing Zhang | Executive Director |
| Lai Ki Chau | Financial Controller and Company Secretary |